EGFR and neoplasm: In summary, the recombinant adenovirus Ad-SLPI-EGFRamiR-SLPI-revCASP3, armed with EGFR targeted artificial microRNA and recombinant caspase-3 under the control of tumor specific promoter SLPI, was successfully constructed.